Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.
作者信息
de Paula Bruno H R, Araújo Indiara, Bandeira Lívia, Barreto Nathália M P B, Doherty Gary J
机构信息
Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
Division of Medicine, Universidade de Vassouras, Vassouras, Brazil.
出版信息
Lancet Oncol. 2020 May;21(5):624-627. doi: 10.1016/S1470-2045(20)30226-6. Epub 2020 Apr 8.
Abstract
摘要
相似文献
1
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.国家监管机构关于在新冠疫情期间正在进行的癌症试验的建议。
Lancet Oncol. 2020 May;21(5):624-627. doi: 10.1016/S1470-2045(20)30226-6. Epub 2020 Apr 8.
2
Cancer guidelines during the COVID-19 pandemic.2019冠状病毒病大流行期间的癌症指南。
Lancet Oncol. 2020 May;21(5):629-630. doi: 10.1016/S1470-2045(20)30217-5. Epub 2020 Apr 2.
3
Acting on misinformation to prevent patient harm.依据错误信息采取行动以防止患者受到伤害。
Lancet Oncol. 2020 Sep;21(9):1123. doi: 10.1016/S1470-2045(20)30487-3.
4
Conducting Clinical Research in the Era of Covid-19.在新冠疫情时代开展临床研究。
Am J Med Sci. 2020 Sep;360(3):213-215. doi: 10.1016/j.amjms.2020.06.011. Epub 2020 Jun 10.
5
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.新型冠状病毒病 2019（COVID-19）疫情与癌症临床试验入组的相关性。
JAMA Netw Open. 2020 Jun 1;3(6):e2010651. doi: 10.1001/jamanetworkopen.2020.10651.
6
Effect of the COVID-19 pandemic on cancer treatment and research.2019冠状病毒病大流行对癌症治疗及研究的影响。
Lancet Haematol. 2020 Jun;7(6):e432-e435. doi: 10.1016/S2352-3026(20)30123-X. Epub 2020 Apr 24.
7
UK cancer care threatened by government incompetence.英国癌症护理受到政府不作为的威胁。
Lancet Oncol. 2020 Nov;21(11):1387. doi: 10.1016/S1470-2045(20)30638-0. Epub 2020 Oct 22.
8
UK government's work to tackle health disparities of covid-19.英国政府应对新冠疫情健康差异的工作。
BMJ. 2020 Jul 24;370:m2920. doi: 10.1136/bmj.m2920.
9
Oncology Clinical Trials During the COVID-19 Pandemic.肿瘤学临床试验在 COVID-19 大流行期间。
Oncology (Williston Park). 2020 Jul 15;34(7):265-269.
10
Policy Lessons from Our Covid Experience.我们新冠疫情经历中的政策教训。
N Engl J Med. 2020 Oct 22;383(17):e96. doi: 10.1056/NEJMp2023204. Epub 2020 Aug 26.
引用本文的文献
1
Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial.瑞戈非尼联合信迪利单抗作为微卫星稳定型转移性结直肠癌的挽救治疗：一项单臂、开放标签的II期临床试验。
Nat Commun. 2025 Feb 10;16(1):1481. doi: 10.1038/s41467-025-56748-3.
2
Exploring the divergence in perspectives on clinical trial operations in South Korea during the COVID-19 pandemic: a comparison of a trial site and sponsors.探索新冠疫情期间韩国临床试验运营视角的差异：试验场所与申办方的比较
Front Med (Lausanne). 2024 Mar 6;11:1342184. doi: 10.3389/fmed.2024.1342184. eCollection 2024.
3
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement.意大利肿瘤医学协会关于 COVID-19 对意大利肿瘤学影响的立场文件及未来发展路径：2021 年马泰拉声明。
ESMO Open. 2022 Aug;7(4):100538. doi: 10.1016/j.esmoop.2022.100538. Epub 2022 Jun 23.
4
Rethinking cancer clinical trials for COVID-19 and beyond.重新思考癌症临床试验在 COVID-19 及以后的应用。
Nat Cancer. 2020 Jun;1(6):568-572. doi: 10.1038/s43018-020-0083-x.
5
When innovation outpaces regulations: The legal challenges for direct-to-patient supply of investigational medicinal products.当创新超越法规时：直接向患者供应研究性药品的法律挑战。
Br J Clin Pharmacol. 2022 Mar;88(3):1115-1142. doi: 10.1111/bcp.15040. Epub 2021 Oct 13.
6
Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan.
Front Oncol. 2021 May 28;11:560585. doi: 10.3389/fonc.2021.560585. eCollection 2021.
7
The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.2019年冠状病毒病对国家临床试验网络乳腺癌试验的影响
Curr Breast Cancer Rep. 2021;13(3):103-109. doi: 10.1007/s12609-021-00417-z. Epub 2021 May 12.
8
Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420).2019年冠状病毒病大流行对拉丁美洲肿瘤临床研究的影响（拉丁美洲肿瘤学合作组织0420）
JCO Glob Oncol. 2021 Apr;7:649-658. doi: 10.1200/GO.20.00663.
9
Addressing COVID-19 challenges in a randomised controlled trial on exercise interventions in a high-risk population.在一项针对高危人群运动干预的随机对照试验中应对 COVID-19 挑战。
BMC Geriatr. 2021 May 1;21(1):287. doi: 10.1186/s12877-021-02232-8.
10
Nobody dares stopping clinical research, not even COVID-19.没有人敢停止临床研究，即使是新冠疫情也不行。
NPJ Breast Cancer. 2021 Apr 8;7(1):39. doi: 10.1038/s41523-021-00249-1.
本文引用的文献
1
Facilitating access to new therapeutic options through clinical trials: the vision of a regulator to reconcile innovation and safety.
Ann Oncol. 2019 Nov 1;30(11):1694-1696. doi: 10.1093/annonc/mdz389.
2
Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.系统评价和荟萃分析癌症临床试验参与的结构、临床以及医生和患者障碍的程度。
J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.
Zotero 插件